Cargando…
Repairing of N-mustard derivative BO-1055 induced DNA damage requires NER, HR, and MGMT-dependent DNA repair mechanisms
Alkylating agents are frequently used as first-line chemotherapeutics for various newly diagnosed cancers. Disruption of genome integrity by such agents can lead to cell lethality if DNA lesions are not removed. Several DNA repair mechanisms participate in the recovery of mono- or bi-functional DNA...
Autores principales: | Kuo, Ching-Ying, Chou, Wen-Cheng, Wu, Chin-Chung, Wong, Teng-Song, Kakadiya, Rajesh, Lee, Te-Chang, Su, Tsann-Long, Wang, Hui-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694865/ https://www.ncbi.nlm.nih.gov/pubmed/26208482 |
Ejemplares similares
-
BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma models
por: Ambati, Srikanth R., et al.
Publicado: (2016) -
Enhancement of radiosensitivity in human glioblastoma cells by the DNA N-mustard alkylating agent BO-1051 through augmented and sustained DNA damage response
por: Chu, Pei-Ming, et al.
Publicado: (2011) -
Alteration of the Nucleotide Excision Repair (NER) Pathway in Soft Tissue Sarcoma
por: Pasqui, Adriano, et al.
Publicado: (2022) -
mTOR inhibition and levels of the DNA repair protein MGMT in T98G glioblastoma cells
por: Smalley, Sarah, et al.
Publicado: (2014) -
The role of direct DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) in high grade malignant glioma
por: Manoj, M Jeru, et al.
Publicado: (2014)